PAZOPANIB

PAZOPANIB (10041L)

pazopanib 400 mg tablet, 60
10041L
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 9247)

Indication: Advanced (unresectable and/or metastatic) soft tissue sarcoma
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 2 DPMQ: $1,736.78 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pazopanib ADVZ
Pazopanib Dr.Reddy's
Pazopanib-RZ
Votrient

PAZOPANIB (10043N)

pazopanib 400 mg tablet, 60
10043N
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 7458)

Indication: Advanced (unresectable and/or metastatic) soft tissue sarcoma
Treatment phase: Continuing treatment beyond 3 months
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $1,736.78 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pazopanib ADVZ
Pazopanib Dr.Reddy's
Pazopanib-RZ
Votrient

PAZOPANIB (11261Q)

pazopanib 400 mg tablet, 60
11261Q
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 11937)

Indication: Stage IV clear cell variant renal cell carcinoma (RCC)
Treatment phase: Continuing treatment beyond 3 months
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $1,736.78 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pazopanib ADVZ
Pazopanib Dr.Reddy's
Pazopanib-RZ
Votrient

PAZOPANIB (2030W)

pazopanib 400 mg tablet, 60
2030W
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 11974)

Indication: Stage IV clear cell variant renal cell carcinoma (RCC)
Treatment phase: Initial treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 2 DPMQ: $1,736.78 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Pazopanib ADVZ
Pazopanib Dr.Reddy's
Pazopanib-RZ
Votrient